Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne

HANGZHOU and SHAOXING, China, Jan. 24, 2024 /PRNewswire/ — Ascletis Pharma Inc.…

OKX Ventures Leads Strategic Investment in Cross-Layer 2 Protocol Orbiter Finance

SINGAPORE, Jan. 24, 2024 /PRNewswire/ — OKX Ventures, the investment arm of…

AHA Aiken Zou Shasha Attends World Economic Forum, Launching AHA ESG Global Office

SHANGHAI, Jan. 24, 2024 /PRNewswire/ — From January 15 to 19, more…

Global Times: Maestro baritone Liao Changyong pioneers efforts in elevating Chinese art songs worldwide

BEIJING, Jan. 24, 2024 /PRNewswire/ — Listening to his Chinese songs, you…

Gate.io's Proof of Reserves Report Reveals $4.3B in Assets with 115% Reserve Ratio for 171 Assets

PANAMA CITY, Jan. 24, 2024 /PRNewswire/ — Gate.io, a leading crypto exchange…

IPC Shopping Centre Soars Into 2024 with A Loong Ma-Jestic Lunar New Year Showcase

The shopping centre embarks on a new decade with its community with…

Hankyu Hanshin Department Stores' Flagship Hankyu Umeda Main Store in Osaka Holding Japan's Largest Valentine's Day Chocolate Expo 2024

OSAKA, Japan, Jan. 24, 2024 /PRNewswire/ —  – Japan’s Excitement for Valentine’s…

PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions

Eli Lilly and Company, Santec Holdings Corporation participated in the round TOKYO,…